BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251211
DTSTAMP:20260404T143940
CREATED:20251207T213651Z
LAST-MODIFIED:20251207T213722Z
UID:10000462-1765324800-1765411199@oncodaily.com
SUMMARY:Assessing Physical Function in Transplantation and CAR T Recipients
DESCRIPTION:“Assessing Physical Function in Transplantation and CAR T Recipients” is a free panel-based webinar offered by the ASTCT Survivorship SIG (American Society for Transplantation and Cellular Therapy) and is scheduled for December 10\, 2025\, at 12:00 PM CST. \nThe webinar’s focus is on clinical practice and research\, aiming to help attendees identify and understand the currently available physical assessment tools for evaluating physical function in patients before\, during\, and after receiving hematopoietic cell transplantation (HCT) or CAR T-cell therapies. The expert panel includes speakers such as Shatha Farhan\, MD\, and Shernan Holtan\, MD\, and the goal is to bridge knowledge gaps and encourage the optimized use of these tools in clinical practice. \nRegister.
URL:https://oncodaily.com/event/car-t-423761
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ASTCT.webp
ORGANIZER;CN="American Society for Transplantation and Cellular Therapy (ASTCT)":MAILTO:info@astct.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251213
DTSTAMP:20260404T143940
CREATED:20251105T195850Z
LAST-MODIFIED:20251105T195909Z
UID:10000323-1765324800-1765583999@oncodaily.com
SUMMARY:Flash Radiotherapy and Particle Therapy 2025 Conference
DESCRIPTION:The FRPT (Flash Radiotherapy and Particle Therapy) 2025 Conference is a major multidisciplinary forum dedicated to uniting cutting-edge radiation therapies with groundbreaking research and clinical trials. The conference is scheduled for December 10–12\, 2025\, and will be held in Prague\, the Czech Republic. Over three days\, the event will showcase the latest updates on FLASH and particle therapy across basic science\, preclinical research\, clinical trials\, and treatment\, bringing together leading researchers\, clinicians\, industry providers\, and an international audience.
URL:https://oncodaily.com/event/flash-radiotherapy-403709
LOCATION:Clarion Congress Hotel Prague\, Freyova 945/33\, Prague\, Hlavni mesto Praha\, 190 00\, Czech Republic
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/475381440_577404905272763_6856074363405834217_n.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251210
DTEND;VALUE=DATE:20251214
DTSTAMP:20260404T143940
CREATED:20251128T234953Z
LAST-MODIFIED:20251128T235011Z
UID:10000420-1765324800-1765670399@oncodaily.com
SUMMARY:AOFOG-ASGO Gynecologic Oncology Research Workshop
DESCRIPTION:The AOFOG-ASGO Gynecologic Oncology Research Workshop (AGORE) is scheduled for December 10–13\, 2025\, and will be held at the Skycity Marriott in Hong Kong. \nThis event is specifically designed for gynecological oncology fellows and oncologists\, offering a unique opportunity to enhance their research skills through a program featuring engaging lectures\, mentoring sessions\, and hands-on workshops\, with the goal of advancing research expertise in the field. \nRegister.
URL:https://oncodaily.com/event/gynecologic-oncology-418164
LOCATION:Hong Kong SkyCity Marriott Hotel\, International Airport\, 1 Sky City Rd E\, Lantau Island\, Hong Kong\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/Screenshot-2025-11-29-034455.webp
ORGANIZER;CN="Asian Society of Gynecologic Oncology":MAILTO:adminoffice@asiansgo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251210T080000
DTEND;TZID=Europe/London:20251212T170000
DTSTAMP:20260404T143940
CREATED:20250701T130014Z
LAST-MODIFIED:20250701T130110Z
UID:10000206-1765353600-1765558800@oncodaily.com
SUMMARY:ESMO Immuno-Oncology Congress 2025
DESCRIPTION:The ESMO Immuno-Oncology Congress 2025 will be held from 10 to 12 December 2025 as a hybrid event\, both onsite in London\, UK\, and online. This leading international congress brings together experts from around the globe to explore the full spectrum of immuno-oncology from basic science and translational research to clinical advancements. Attendees can expect cutting-edge sessions\, in-depth learning opportunities\, and dynamic networking with peers\, researchers\, and industry leaders. \nThe programme includes immersion sessions focused on immunobiology and translational insights\, updates on checkpoint inhibitor-based therapies\, and the latest in immune modulation including tumour microenvironment\, immunometabolism\, and cell signaling. Participants will also engage with industry and independent investigators to explore developments in cellular therapies\, cancer vaccines\, intratumoural immunotherapy\, and multispecific constructs. \nWhether attending in person or online\, the congress offers a valuable platform to share research\, expand knowledge\, and shape the future of cancer immunotherapy. \nRegistration is Open for the Event. \nMore posts featuring ESMO.
URL:https://oncodaily.com/event/esmo-immuno-oncology-congress-2025-321830
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_6227.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251210T083000
DTEND;TZID=America/Halifax:20251210T120000
DTSTAMP:20260404T143940
CREATED:20251206T001840Z
LAST-MODIFIED:20251206T001927Z
UID:10000455-1765355400-1765368000@oncodaily.com
SUMMARY:ESMO-IO SITC Primer Program
DESCRIPTION:The ESMO-IO SITC Primer Program is a joint educational event organized by the European Society for Medical Oncology (ESMO) and the Society for Immunotherapy of Cancer (SITC)\, scheduled for December 10\, 2025\, from 8:30 a.m. to 12:00 p.m. BST. \nThis half-day primer\, held at the Queen Elizabeth II Centre in London\, UK\, focuses on fundamental immuno-oncology (IO) concepts. \nThe program will cover current and emerging topics in immuno-oncology (IO)\, including neoadjuvant immunotherapy\, intratumoral immunotherapies\, recombinant cytokines\, and bispecific antibodies\, alongside new applications of AI\, spatial biology\, and multiomic approaches.
URL:https://oncodaily.com/event/esmo-422513
LOCATION:Queen Elizabeth II Centre in London\, United Kingdom\, Broad Sanctuary\, London SW1P 3EE\, London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMOSITC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
DTSTAMP:20260404T143940
CREATED:20251129T231515Z
LAST-MODIFIED:20251129T231525Z
UID:10000424-1765411200-1765497599@oncodaily.com
SUMMARY:The Role of Modern Radiotherapy for Low Grade Glioma
DESCRIPTION:The educational webinar titled “The Role of Modern Radiotherapy for Low Grade Glioma\,” part of the Educational Lectures on Paediatric Radiation Oncology Series\, will be held virtually on December 11\, 2025\, at 16:00 CET (Central European Time). \nThis open-to-all session will feature speaker Danny Indelicato\, Professor in the Department of Radiation Oncology at the University of Florida. The webinar will discuss how radiotherapy integrates into contemporary options for managing pediatric low-grade glioma. \nRegister.
URL:https://oncodaily.com/event/low-grade-glioma-418629
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/glioma.webp
ORGANIZER;CN="International Society of Paediatric Oncology (SIOP)":MAILTO:info@siop-online.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
DTSTAMP:20260404T143940
CREATED:20251129T232432Z
LAST-MODIFIED:20251129T232445Z
UID:10000425-1765411200-1765497599@oncodaily.com
SUMMARY:Advancing Pediatric ALL Care: Adapting Global Standards for LMICs
DESCRIPTION:The webinar “Advancing Pediatric ALL Care: Adapting Global Standards for LMICs“ will be held virtually on Thursday\, December 11\, 2025\, at 2 PM CET/Geneva. \nThis session focuses on sharing Global Updates and Future Directions in pediatric ALL care and specifically addressing how to translate and implement these advancements From Evidence to Practice in Resource-Limited Settings (LMICs)\, featuring a keynote presentation by Prof. Hiroto Inaba and experience-sharing from SIOP Asia Country Ambassadors. \nRegister.
URL:https://oncodaily.com/event/advancing-pediatric-all-care-418632
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ALL.webp
ORGANIZER;CN="International Society of Paediatric Oncology (SIOP)":MAILTO:info@siop-online.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251212
DTSTAMP:20260404T143940
CREATED:20251207T213917Z
LAST-MODIFIED:20251207T214051Z
UID:10000463-1765411200-1765497599@oncodaily.com
SUMMARY:BMT Across the World: Who Makes What and Who Pays Whom?
DESCRIPTION:“BMT Across the World: Who Makes What and Who Pays Whom?” is Part 1 of a joint educational series hosted by the ASTCT (American Society for Transplantation and Cellular Therapy) and the EBMT (European Society for Blood and Marrow Transplantation)\, scheduled for December 11\, 2025\, at 9:00 AM CST. \nFocusing on allogeneic Bone Marrow Transplantation (BMT)\, the session aims to explore the significant variations in the clinical\, logistical\, administrative\, and reimbursement landscapes for BMT therapies across different countries. Key topics include how BMT is regulated\, implemented\, and paid for globally\, alongside a critical appraisal of emerging innovations in areas such as GVHD prophylaxis\, conditioning regimens\, and relapse prevention. \nRegister.
URL:https://oncodaily.com/event/bmt-across-the-world-423766
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ASTCT.webp
ORGANIZER;CN="American Society for Transplantation and Cellular Therapy (ASTCT)":MAILTO:info@astct.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251211
DTEND;VALUE=DATE:20251213
DTSTAMP:20260404T143940
CREATED:20251128T234245Z
LAST-MODIFIED:20251128T234328Z
UID:10000419-1765411200-1765583999@oncodaily.com
SUMMARY:33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors
DESCRIPTION:The 33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors is a two-day scientific meeting organized by the TTD Group (Digestive Tumor Treatment Group). \nThe event will be held from December 11 to December 12\, 2025\, at the Exhibition and Congress Palace in Oviedo\, Spain. The symposium will feature presentations and discussions on the latest advances in treating various digestive tumors.
URL:https://oncodaily.com/event/international-ttd-symposium-418159
LOCATION:Oviedo Congress and Exhibitions Center\, C. Arturo Álvarez Buylla\, Oviedo\, Asturias\, 33005\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/170225_102024_1958259862.webp
ORGANIZER;CN="TTD Group (Digestive Tumor Treatment Group)":MAILTO:ttd@ttdgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251213
DTEND;VALUE=DATE:20251215
DTSTAMP:20260404T143940
CREATED:20251124T212249Z
LAST-MODIFIED:20251124T212304Z
UID:10000398-1765584000-1765756799@oncodaily.com
SUMMARY:Best of ESMO India 2025
DESCRIPTION:The Best of ESMO India 2025 is an ESMO-licensed event making its Indian debut in Mumbai\, scheduled for December 13–14\, 2025. \nThis conference\, hosted by the Global Healthcare Academy (GHA)\, is a major platform for disseminating the most recent\, cutting-edge data and clinical practices from the main European Society for Medical Oncology (ESMO) Congress. \nDesigned for a multidisciplinary audience including medical\, surgical\, and radiation oncologists\, the event will feature focus sessions guided by an extensive advisory\, core\, and scientific committee comprising leading Indian oncologists\, and will be held at The St. Regis Mumbai. \nRegister.
URL:https://oncodaily.com/event/best-of-esmo-india-415818
LOCATION:The St. Regis Mumbai\, 462 Senapati Bapat Marg\, Lower Parel\, Mumbai\, Maharashtra\, 400013\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251218
DTSTAMP:20260404T143940
CREATED:20251124T213007Z
LAST-MODIFIED:20251124T213103Z
UID:10000399-1765843200-1766015999@oncodaily.com
SUMMARY:ESMO Preceptorship on Prostate Cancer 2025: Lugano
DESCRIPTION:The ESMO Preceptorship on Prostate Cancer 2025: Lugano is a two-day educational course focusing on a thorough understanding of prostate cancer management\, from diagnosis to treatment\, according to current standards of care. \nOrganized by the European Society for Medical Oncology (ESMO)\, the event is scheduled to take place on December 16–17\, 2025\, in Lugano\, Switzerland. The preceptorship is designed primarily for medical and clinical oncologists\, especially young oncologists\, and has been accredited for 9 ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/preceptorship-on-prostate-cancer-415823
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/09/1756803627507.jpeg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251216
DTEND;VALUE=DATE:20251219
DTSTAMP:20260404T143940
CREATED:20251128T233427Z
LAST-MODIFIED:20251128T233443Z
UID:10000418-1765843200-1766102399@oncodaily.com
SUMMARY:1st National Oncology Nursing Conference
DESCRIPTION:The Oncology Nursing Society of Nigeria (ONSN) is hosting its 1st National Oncology Nursing Conference titled “Oncology Nursing in the Spotlight: Celebrating Excellence and Inspiring Growth.” \nThe conference is scheduled for December 16–18\, 2025\, at Babcock University in Ilishan Remo\, Ogun State\, Nigeria. \nThis landmark event aims to bring together over 500 local and international nursing leaders\, researchers\, clinicians\, and policymakers to strengthen cancer care delivery and workforce development across Nigeria and Africa. Attendees will gain actionable strategies for advancing oncology nursing practice\, policy\, and research.
URL:https://oncodaily.com/event/national-oncology-nursing-418154
LOCATION:Babcock University Ilishan Remo\, VPQ9+VPP\, Ilishan-Remo\, Ilishan-Remo\, Ogun State\, 121103\, Nigeria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/NONC.webp
ORGANIZER;CN="Oncology Nursing Society of Nigeria (ONSN)":MAILTO:info@onsnigeria.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251216T130000
DTEND;TZID=America/Halifax:20251216T174000
DTSTAMP:20260404T143940
CREATED:20251031T222606Z
LAST-MODIFIED:20251031T222623Z
UID:10000305-1765890000-1765906800@oncodaily.com
SUMMARY:Digestive Oncology Autumn Symposium\, Edition 2025
DESCRIPTION:The Digestive Oncology Autumn Symposium\, Edition 2025\, is scheduled for the afternoon of Tuesday\, December 16\, 2025\, at Salons De Romree in Grimbergen\, Belgium. The event will begin with a lunch from 1:00 PM to 2:00 PM\, followed by the scientific presentations from 2:00 PM to 5:40 PM. This annual congress is presented by The Merck Medical Team and is a premier gathering for professionals interested in Antibody-Drug Conjugates (ADCs). \nThe symposium features a distinguished faculty of speakers and moderators\, including Professor Sabine Tejpar (UZ Leuven)\, Dr. Gertjan Rasschaert (UZ Leuven/ZAS Antwerpen)\, and Dr. Jochen Decaestecker (AZ Delta). They will be joined by international experts like Dr. Elizabeth Smyth (Oxford University\, UK) and Dr. Pia Österlund (Karolinska University Hospital\, Sweden). Attendees from over five countries will discuss the latest insights in digestive oncology. \nRegister.
URL:https://oncodaily.com/event/digestive-oncology-401430
LOCATION:Salons De Romree\, Beiaardlaan 31\, Grimbergen\, Flemish Brabant\, 1850\, Belgium
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/10/Screenshot-2025-11-01-021722.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251216T200000
DTEND;TZID=America/Halifax:20251217T000000
DTSTAMP:20260404T143940
CREATED:20251109T181010Z
LAST-MODIFIED:20251109T181029Z
UID:10000330-1765915200-1765929600@oncodaily.com
SUMMARY:The State of AI in Precision Oncology 2025
DESCRIPTION:The State of AI in Precision Oncology 2025 is the third annual\, free virtual summit hosted by the journal AI in Precision Oncology\, aiming to assess the current evolution of medicine driven by Artificial Intelligence\, specifically within the field of oncology. \nScheduled for Tuesday\, Dec 16\, 2025 at 8:00 PM – Wednesday\, Dec 17\, 2025 at 12:00 AM (+04)\, the event features keynote interviews\, presentations\, and fireside chats with renowned experts like Amy Abernethy (former FDA executive)\, Isaac Kohane (Founding Editor of NEJM AI)\, and Connie Lehman (on AI in breast cancer screening). \nThe summit documents how clinicians are increasingly deploying AI applications and strategies to personalize treatments and transform their practice\, covering topics from blood-based cancer screening to the state of AI in community hospitals and a look ahead to “AI in Oncology 2030.”
URL:https://oncodaily.com/event/ai-in-precision-oncology-406089
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/AI-in-Precision-Oncology.jpg
ORGANIZER;CN="AI in Precision Oncology":MAILTO:AIPO_EO@liebertpub.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251217
DTEND;VALUE=DATE:20251218
DTSTAMP:20260404T143940
CREATED:20251203T223414Z
LAST-MODIFIED:20251203T223426Z
UID:10000436-1765929600-1766015999@oncodaily.com
SUMMARY:EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC
DESCRIPTION:The EORTC Lung Cancer Group Multidisciplinary Webinar on Clinical Trials in Stage III NSCLC is scheduled for December 17\, 2025\, at 18:00 CET. This free\, open-to-all online event will feature experts from medical oncology\, radiation oncology\, and thoracic surgery who will explore and discuss the status of current as well as upcoming clinical trials focused on the treatment of Stage III non-small cell lung cancer. \nRegister.
URL:https://oncodaily.com/event/eortc-421170
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/EORTC.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251217T130000
DTEND;TZID=America/Halifax:20251217T141500
DTSTAMP:20260404T143940
CREATED:20251206T173920Z
LAST-MODIFIED:20251206T173950Z
UID:10000456-1765976400-1765980900@oncodaily.com
SUMMARY:SITC Webinar on Bispecifics and T Cell Engagers: Practical Strategies for Recognizing and Managing Toxicities
DESCRIPTION:The SITC Webinar on Bispecifics and T cell Engagers: Practical Strategies for Recognizing and Managing Toxicities is a virtual\, multi-stakeholder event scheduled for December 17\, 2025\, from 1:00 p.m. to 2:15 p.m. ET. The webinar will feature expert faculty\, including Sid Devarakonda\, MD\, and Megan May\, PharmD\, to provide clinical insights into the use of bispecifics and T cell engagers and the necessary management of their associated toxicity. \nThe primary focus is on identifying and employing best practices for treating immune-related adverse events (irAEs)\, particularly Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)\, with the goal of improving patient outcomes through multidisciplinary and collaborative approaches. \nRegister.
URL:https://oncodaily.com/event/bispecifics-and-t-cell-engagers-422941
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/sitc.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20251217T140000
DTEND;TZID=America/Halifax:20251217T150000
DTSTAMP:20260404T143940
CREATED:20251207T214247Z
LAST-MODIFIED:20251207T214307Z
UID:10000464-1765980000-1765983600@oncodaily.com
SUMMARY:Going Full TILt: Challenges\, Successes\, and Coordination with Administering TIL Therapy
DESCRIPTION:“Going Full TILt: challenges\, successes\, and coordination with administering TIL therapy” is an upcoming “Rx-cited: Clinical Conundrums” roundtable organized by the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task Force\, scheduled for Wednesday\, December 17\, 2025\, from 2:00–3:00 PM CST. \nThe session is designed to be an informal Q&A discussion focusing on the challenges\, key points\, and future directions associated with offering Tumor Infiltrating Lymphocyte (TIL) therapy\, providing a space for both members and non-members working in transplantation and cellular therapy to connect and share insights on these latest advancements. \nRegister.
URL:https://oncodaily.com/event/going-full-tilt-423772
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ASTCT.webp
ORGANIZER;CN="American Society for Transplantation and Cellular Therapy (ASTCT)":MAILTO:info@astct.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260108T080000
DTEND;TZID=America/Halifax:20260110T170000
DTSTAMP:20260404T143940
CREATED:20250713T084301Z
LAST-MODIFIED:20250713T084336Z
UID:10000213-1767859200-1768064400@oncodaily.com
SUMMARY:ASCO Gastrointestinal Cancers Symposium 2026
DESCRIPTION:The 2026 ASCO Gastrointestinal Cancers Symposium will take place from January 8–10\, 2026\, at Moscone West in San Francisco\, CA\, as well as online. \nThis annual event gathers oncology professionals from around the world to explore the latest developments in GI cancer treatment\, research\, and patient care. Featuring cutting-edge scientific presentations and multidisciplinary discussions\, the symposium offers a platform for clinicians\, researchers\, and industry experts to exchange insights and shape the future of gastrointestinal oncology. \nWith a focus on innovative science and solution-oriented strategies\, the symposium covers a broad range of GI cancers including colorectal\, pancreatic\, liver\, and esophageal cancers. Attendees can expect expert-led sessions\, abstract presentations\, and practical discussions on integrating new research into clinical practice.
URL:https://oncodaily.com/event/asco-328506
LOCATION:Moscone West\, 800 Howard Street\, San Francisco\, United States
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/asco.jpg
ORGANIZER;CN="American Society of Clinical Oncology (ASCO) Direct":MAILTO:customerservice@asco.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260109
DTEND;VALUE=DATE:20260111
DTSTAMP:20260404T143940
CREATED:20251204T145833Z
LAST-MODIFIED:20251204T145906Z
UID:10000449-1767916800-1768089599@oncodaily.com
SUMMARY:2026 Highlights of ASH in North America
DESCRIPTION:The Highlights of ASH in North America is a two-day program offered by the American Society of Hematology (ASH) in multiple locations to explore and discuss the most influential and novel research presented at the latest ASH Annual Meeting. The program is designed to allow hematology leaders and experts to connect in person\, learn how to apply the latest research to their areas of expertise\, and gain insights into local and regional standards of care. In 2026\, the two-day program will be offered on four separate dates and locations: \n\nChicago\, Illinois | January 9-10\, 2026\nNew York\, New York | January 9-10\, 2026\nWashington\, D.C. | January 16-17\, 2026\nSeattle\, Washington | January 30-31\, 2026\n\nRegister.
URL:https://oncodaily.com/event/ash-in-north-america-421416
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Button-Play-66th-ASH-Annual-Meeting-and-Exposition-1.webp
ORGANIZER;CN="American Society of Hematology":MAILTO:customerservice@hematology.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260114T123000
DTEND;TZID=America/Halifax:20260114T133000
DTSTAMP:20260404T143940
CREATED:20251218T150105Z
LAST-MODIFIED:20251218T150105Z
UID:10000509-1768393800-1768397400@oncodaily.com
SUMMARY:ANCO’s Medicare Regulations Update 2026
DESCRIPTION:The ANCO’s Medicare Regulations Update 2026 webinar on January 14\, 2026\, will provide a comprehensive overview of the latest Medicare changes affecting oncology services. \nBobbi Buell\, MBA\, will cover updates to the Physician Fee Schedule\, coding and billing\, evaluation and management\, and incentive programs\, offering essential insights for clinicians and practice teams. \nRegister here.
URL:https://oncodaily.com/event/anco-430538
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Annotation-2025-12-18-190040-Picsart-AiImageEnhancer.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260115
DTEND;VALUE=DATE:20260116
DTSTAMP:20260404T143940
CREATED:20260106T214303Z
LAST-MODIFIED:20260106T214317Z
UID:10000560-1768435200-1768521599@oncodaily.com
SUMMARY:SEER-MHOS 2026 Update: Your Guide to the New Data Linkage
DESCRIPTION:The SEER-MHOS 2026 Update: Your Guide to the New Data Linkage is a specialized technical webinar hosted by the National Cancer Institute (NCI) Division of Cancer Control and Population Sciences. Scheduled for January 15\, 2026\, this session is designed for health services researchers\, epidemiologists\, and oncology professionals interested in leveraging large-scale data to study cancer survivorship. \nThe webinar focuses on the significant 2025 expansion of the Surveillance\, Epidemiology\, and End Results (SEER) and Medicare Health Outcomes Survey (MHOS) linkage. Key technical updates include the integration of data from 22 SEER registries and the debut of Medicare Advantage Encounter data\, which allows for a more granular analysis of where patients receive both oncology and non-oncology care. \nRegister.
URL:https://oncodaily.com/event/seer-mhos-2026-437625
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/NCI.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260115T200000
DTEND;TZID=America/Halifax:20260115T200000
DTSTAMP:20260404T143940
CREATED:20251130T152939Z
LAST-MODIFIED:20251130T153024Z
UID:10000427-1768507200-1768507200@oncodaily.com
SUMMARY:MASCC Webinar: ADCs and Mucositis: From Mechanism to Care
DESCRIPTION:The MASCC Webinar “ADCs and Mucositis: From Mechanism to Care” on January 15\, 2026\, at 8:00 PM UTC+4 will explore the therapeutic potential and toxicity of antibody-drug conjugates (ADCs)\, with a focus on the recognition\, prevention\, and management of ADC-induced oral mucositis. \nExpert speakers\, including Prof. Paolo Bossi\, Prof. Florian Scotté\, Dr. Barbara Pistilli\, Dr. Emmanuelle Vigarios\, and Dr. Helen Bulbeck\, will share clinical insights\, strategies for supportive care\, and the patient perspective on mucositis. This educational session is supported by an unrestricted grant from Daiichi Sankyo Europe. \nRegister here.
URL:https://oncodaily.com/event/mascc-418960
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/BeFunky-collage-2025-11-30T192911.269.webp
LOCATION:https://oncodaily.com/event/mascc-418960
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260116
DTEND;VALUE=DATE:20260118
DTSTAMP:20260404T143940
CREATED:20251124T213453Z
LAST-MODIFIED:20251124T213510Z
UID:10000400-1768521600-1768694399@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2026: Milan
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management\, covering topics from diagnosis to treatment\, based on current standards of care in a multidisciplinary setting. \nThe preceptorship will take place from January 16–17\, 2026\, in Milan\, Italy. The course is accredited with ESMO-MORA category 1 points\, and the application deadline for attendance is November 25\, 2025. \nApply.
URL:https://oncodaily.com/event/preceptorship-on-breast-cancer-415828
LOCATION:Milan\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260116
DTEND;VALUE=DATE:20260119
DTSTAMP:20260404T143940
CREATED:20251206T181422Z
LAST-MODIFIED:20251206T181441Z
UID:10000459-1768521600-1768780799@oncodaily.com
SUMMARY:Cancer Immunotherapy Winter School 2026
DESCRIPTION:The Cancer Immunotherapy Winter School\, hosted by the Society for Immunotherapy of Cancer (SITC)\, is a hybrid program taking place in Boston and virtually from February 16–18\, 2026\, with the in-person meeting held at The Westin Copley Place\, Boston. \nThe school is tailored for early-to-mid career scientists and clinicians who are new to the field\, providing intensive education from leading experts. The curriculum offers separate clinical and research tracks that cover the fundamental principles of tumor immunology\, cancer immunotherapy\, and developing areas such as biomarker technology\, clinical trial design\, and considerations for combination therapies. Travel awards are available\, and Continuing Education Credits are planned for the program. \nRegister.
URL:https://oncodaily.com/event/cancer-immunotherapy-winter-school-422970
LOCATION:The Westin Copley Place\, Boston\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/CIWS.webp
ORGANIZER;CN="Society for Immunotherapy of Cancer":MAILTO:info@sitcancer.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260116T070000
DTEND;TZID=America/Halifax:20260119T120000
DTSTAMP:20260404T143940
CREATED:20251211T203134Z
LAST-MODIFIED:20251211T203134Z
UID:10000477-1768546800-1768824000@oncodaily.com
SUMMARY:22nd Oncology Updates: Advanced and Controversies Conference
DESCRIPTION:The 22nd Oncology Updates: Advanced and Controversies Conference\, presented by The University of Texas MD Anderson Cancer Center\, is an interactive\, multidisciplinary forum held from Friday\, January 16 to Monday\, January 19\, 2026\, at the Steamboat Grand Hotel in Steamboat Springs\, Colorado. \nThe conference is designed to address the rapidly evolving complexities of solid tumor management\, convening leading experts in surgical\, medical\, and radiation oncology\, among other specialties\, to explore current challenges\, novel therapies\, and clinical controversies through evidence-driven and case-based discussions. \nRegister.
URL:https://oncodaily.com/event/22nd-oncology-updates-426432
LOCATION:Steamboat Grand\, 2300 Mt Werner Cir\, Steamboat Springs\, CO\, 80487\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/22nd-Oncology-Updates.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260116T080000
DTEND;TZID=America/Halifax:20260118T170000
DTSTAMP:20260404T143940
CREATED:20250611T125011Z
LAST-MODIFIED:20250611T125043Z
UID:10000200-1768550400-1768755600@oncodaily.com
SUMMARY:The 2nd Annual Cleveland Clinic Cancer Conference
DESCRIPTION:The 2nd Annual Cleveland Clinic Cancer Conference: Innovations in Multidisciplinary Care will be held from January 16 to 18\, 2026\, in Hollywood\, Florida. \nThis premier event brings together a diverse range of oncology professionals including medical oncologists\, hematologists\, radiation oncologists\, and other healthcare providers to explore the latest developments in cancer diagnosis\, treatment\, and supportive care. Through a combination of evidence-based lectures and case-based discussions\, attendees will gain valuable insights into managing common and complex cancer cases across all disease stages. \nThis conference emphasizes a multidisciplinary approach to cancer care\, with focused sessions on disease-specific updates\, innovative technologies\, and integrative care strategies. Participants can expect to learn about cutting-edge research\, evolving therapeutic options\, and best practices in clinical decision-making. The event also highlights the importance of supportive and non-pharmacologic care\, addressing the broader needs of patients beyond conventional treatments. \nRegistration is Open for The Event. \nYou Can Find More Posts Featuring Cleveland Clinic.
URL:https://oncodaily.com/event/2nd-annual-cleveland-clinic-cancer-conference-311126
LOCATION:Margaritaville Hollywood Beach Resort\, 1111 N Ocean Dr\, Hollywood\, Los Angeles\, United States
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/06/unnamed.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260119
DTEND;VALUE=DATE:20260121
DTSTAMP:20260404T143940
CREATED:20251226T221031Z
LAST-MODIFIED:20251226T221343Z
UID:10000531-1768780800-1768953599@oncodaily.com
SUMMARY:The UK Interdisciplinary Breast Cancer Symposium (UKIBCS 2026)
DESCRIPTION:The UK Interdisciplinary Breast Cancer Symposium (UKIBCS) 2026 is a biennial scientific meeting scheduled for January 19–20\, 2026\, at the International Convention Centre (ICC) in Birmingham\, United Kingdom. \nOrganized through a collaboration between Breast Cancer Now\, the British Oncology Pharmacy Association (BOPA)\, the Association of Breast Surgery (ABS)\, and KC Jones Conference and Events\, the symposium provides a multidisciplinary forum for clinicians\, researchers\, and allied health professionals to examine advancements in breast cancer research and clinical care. \nThe 2026 scientific program features sessions on personalized surgical approaches\, tumor immunology\, the integration of artificial intelligence in pathology\, and clinical trials updates. \nRegister.
URL:https://oncodaily.com/event/ukibcs-434579
LOCATION:International Convention Centre\, UK\, 8 Centenary Sq\, Birmingham\, West Midlands\, B1 2EA\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/UKIBCS-2026.webp
ORGANIZER;CN="Breast Cancer Now":MAILTO:hello@breastcancernow.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260119
DTEND;VALUE=DATE:20260122
DTSTAMP:20260404T143940
CREATED:20260122T150041Z
LAST-MODIFIED:20260122T150041Z
UID:10000614-1768780800-1769039999@oncodaily.com
SUMMARY:ASTRO's Multidisciplinary Head and Neck Cancers Symposium
DESCRIPTION:The 2026 Multidisciplinary Head and Neck Cancers Symposium (MHNCS) will be held February 19–21\, 2026\, at the JW Marriott Desert Springs in Palm Desert\, California.  \nCo‑sponsored by ASTRO\, ASCO\, AHNS\, and SITC\, the symposium brings together experts in surgery\, radiation\, medical oncology\, and immunotherapy to share the latest research\, clinical advances\, and best practices. Focused on patient-centered care and innovative team science\, MHNCS offers interactive sessions\, case discussions\, and networking opportunities for clinicians\, researchers\, and trainees. \nRegister Now.
URL:https://oncodaily.com/event/445049
LOCATION:JW Marriott Desert Springs Resort & Spa\, 74-855 Country Club Drive\, Palm Desert\, CA\, 92260\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/BeFunky-collage-2026-01-22T190041.015.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260120
DTEND;VALUE=DATE:20260122
DTSTAMP:20260404T143940
CREATED:20251117T102905Z
LAST-MODIFIED:20251117T102944Z
UID:10000364-1768867200-1769039999@oncodaily.com
SUMMARY:Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy
DESCRIPTION:The European Association for Cancer Research (EACR) conference\, “Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy\,” is a Virtual Event scheduled for January 20-21\, 2026. This conference explores a paradoxical and radically different approach to cancer therapy: instead of inhibiting the signals that drive cancer\, it focuses on the deliberate hyper-activation of oncogenic signaling pathways. \nAccumulating evidence suggests that excessive stimulation can lead to cancer cell death by causing a further activation of cellular stress responses. The meeting\, chaired by Rene Bernards\, aims to give the audience a fundamentally different perspective on treating advanced cancers where conventional inhibition strategies have failed\, by focusing on drugs that activate oncogenic signaling and the resulting vulnerabilities of cancer cells.
URL:https://oncodaily.com/event/oncogenic-signalling-411018
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/eacr-oncogenic-event-card-1.png
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260120
DTEND;VALUE=DATE:20260125
DTSTAMP:20260404T143940
CREATED:20251109T172616Z
LAST-MODIFIED:20251109T172640Z
UID:10000329-1768867200-1769299199@oncodaily.com
SUMMARY:Better Breathing Week 2026
DESCRIPTION:The Better Breathing Week 2026 is the 43rd annual accredited lung health conference presented by the Lung Health Foundation\, scheduled to take place from January 20–24\, 2026\, both in-person at the Hyatt Regency in Toronto\, Canada\, and virtually. As one of Canada’s leading respiratory medical conferences\, it brings together healthcare professionals\, researchers\, policymakers\, and patient advocates to explore the latest innovations and drive meaningful change in respiratory care. \nThe program focuses on breaking down silos and uniting disciplines\, with highlights including dedicated sessions for primary care providers on topics like spirometry access\, vaccine uptake\, and severe asthma identification. The conference is accredited for Continuing Professional Development (CPD)\, offering physicians up to 27.5 Mainpro+ credits for Family Medicine Specialists and 27.5 hours (Section 1) for Royal College Specialists. \nRead more about this event.
URL:https://oncodaily.com/event/better-breathing-week-406067
LOCATION:Hyatt Regency Toronto\, 370 King Street West\, PO Box 137\, Toronto\, Ontario (ON)\, M5V 1J9\, Canada
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/Better-Breathing-Week.jpg
ORGANIZER;CN="Lung Health Foundation":MAILTO:info@lunghealth.ca
END:VEVENT
END:VCALENDAR